Testosterone gel ads serve important educational role, companies say

10/17/2013 | New York Times (tiered subscription model), The

Some doctors said direct advertising for testosterone gels may be bad for consumers while driving up health care costs. The medical benefit of the gels is unproven and they can have dangerous side effects, doctors said. A representative of AbbVie Pharmaceuticals, which sells AndroGel, said the campaigns help educate patients and spark important conversations between men and their doctors.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care